Soins de la santé

36

PROFESSIONNELS EXPÉRIMENTÉS

282

TRANSACTIONS COMPLÉTÉES

52

MANDATS EN COURS

Les professionnels d’Oaklins comprennent les enjeux locaux et internationaux entourant la réglementation, les remboursements, la technologie, la médecine et les patients du secteur. Nous connaissons les grands joueurs et nous avons une vision globale de toutes les transactions de fusions et acquisitions. Nous repérons les bons partenaires stratégiques, nous optimisons les synergies potentielles et nous obtenons des offres intéressantes pour nos clients. C'est la façon Oaklins.

TRANSACTIONS RÉCENTES
SOINS DE LA SANTÉ

Tombstone image
Tombstone image
Tombstone image
Tombstone image
Tombstone image
Tombstone image
Tombstone image

PRINCIPAUX CONTACTS DU SECTEUR

Pierre Mathieu

Canada

Associé

AFFICHER LE PROFIL

Yves A. Sicard

Canada

Associé directeur

AFFICHER LE PROFIL

DERNIÈRES NOUVELLES D’OAKLINS

Oaklins’ team in Russia will join SFM Group at the BIO 2017

9 mai 2017
Our client, SFM Group, is going to attend the world’s largest global biotechnology event BIO 2017 International Convention taking place from 19–22 June 2017 in San Diego, USA. SFM Group, is an innovative Russian pharmaceutical company specializing in pharma R&D and has its own production facilities. Its product portfolio includes medicines to treat cardio-vascular diseases, viral infections, regenerative medicines, etc. Its breakthrough product is Trombovazim, a powerful thrombolytic…

POUR EN SAVOIR PLUS

Globalizing cutting edge technology in point-of-care patient blood management

30 novembre 2016
DEAL FLASH: Oaklins’ team in Switzerland advised the shareholders of TEM Group on the sale of the company to Instrumentation Laboratory (IL). The team acted as lead advisor to the shareholders of TEM Group throughout the sale process. This deal demonstrates the value and competitive advantage Oaklins provides in guiding the client in a very close personal relationship through all stages of the process. Read…

POUR EN SAVOIR PLUS

Shareholder succession at Sphinx Werkzeuge AG

29 septembre 2016
The owners of Sphinx Werkzeuge AG have sold a majority stake in the company to Helvetica Capital AG and members of the management team. Financial details were not disclosed. Sphinx Werkzeuge is a leading precision tools developer and manufacturer for high precision mechanical and medical applications. The company’s core business is the production of micro to small drills. In the medical technology industry, its products…

POUR EN SAVOIR PLUS

Instrumentation Laboratory Acquires CA CASYSO AG, Including TEM® subsidiaries and ROTEM® Testing Systems

26 septembre 2016
Instrumentation Laboratory (IL) acquired CA Casyso AG (Basel, Switzerland) and its Tem subsidiaries (Tem), a global leader in in vitro diagnostic (IVD) testing for Patient Blood Management (PBM) with their flagship ROTEM testing systems. Tem is a global leader in in-vitro-diagnostic (IVD) testing for Patient Blood Management (PBM) with their flagship ROTEM testing systems. With a direct sales force in seven markets, including the US,…

POUR EN SAVOIR PLUS

A new rehabilitation pathway for acquired brain injuries

29 avril 2016
DEAL FLASH:  Smith & Williamson advised the shareholders of Oakleaf Care (Hartwell) Limited (Oakleaf) on the sale of the company to CareTech Holdings Plc (CareTech). Oakleaf provides brain injury rehabilitation to adult males requiring specialist care and long-term support. The in-depth healthcare sector knowledge and experience of our team of advisors was crucial to achieving a successful sale. Read more about the transaction, market trends,…

POUR EN SAVOIR PLUS

Cross-border deal in biosimilars

26 novembre 2015
HEALTHCARE DEAL FLASH:  Oaklins’ Swedish and Italian teams advised the shareholders of Xbrane Biosciences AB (Xbrane) on the acquisition of Primm Pharma. They supported the buyer by scouting the Italian market, identifying the most suitable target, and assisting in the LOI formulation and in negotiations throughout the process. Through the acquisition, Xbrane will be able to broaden their expertise within the field of high demand…

POUR EN SAVOIR PLUS

Consolidation continues in the dental industry

16 octobre 2015
HEALTHCARE DEAL FLASH:  Our Oaklins’ team in the Netherlands and Cavendish, an Oaklins member firm in the UK, advised the shareholders of C.D.C. Complete tandzorg (CDC) in the sale of a stake in the company to G Square Healthcare Private Equity. The partnership will enable CDC to expand its dental care services to other regions in the Netherlands by opening new dental practices. Read more…

POUR EN SAVOIR PLUS